Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Caring Brands Incorporation ( (CABR) ) has shared an announcement.
On February 3, 2026, Caring Brands Inc. announced that it had secured two new U.S. patents, granted in January 2026, for proprietary methods and compositions that enhance sulfotransferase enzyme activity in hair follicles, bolstering the intellectual property underpinning its Hair Enzyme Booster product. The patents extend the company’s exclusive protection over key mechanisms intended to improve the efficacy of topical hair loss treatments and support broader patient responsiveness, reinforcing its competitive position in the hair-loss treatment market while underpinning ongoing commercialization through U.S. direct sales and international licensees and advancing its strategy to build a differentiated portfolio in hair and skin health.
More about Caring Brands Incorporation
Caring Brands Inc., listed on Nasdaq as CABR, operates in the skin and hair health sector with a portfolio of patented, clinically validated products targeting conditions such as hair loss, psoriasis, vitiligo, and eczema. The company currently generates revenue from its Hair Enzyme Booster for hair loss and Photocil for psoriasis and vitiligo through direct U.S. sales and licensees in India, and is pursuing a strategy centered on rapid product development, intellectual property expansion, and international licensing for additional products including CB-101 for eczema and NoStingz, a sunscreen that prevents jellyfish stings.
Average Trading Volume: 348,260
Technical Sentiment Signal: Strong Sell
Current Market Cap: $11.58M
See more insights into CABR stock on TipRanks’ Stock Analysis page.